Comparative Analysis of Inflammatory Markers (CRP, TLC, ESR) between Gestational Diabetes and Non-Diabetic Pregnant Females in Rawalpindi, Pakistan

Authors

  • Atif Rafique Zohra Institute of Health Sciences (GCUF), Rawalpindi, Punjab, Pakistan.
  • Naila Yasin COMSATS University, Islamabad, Pakistan.
  • Anam Hanif University of Sargodha, Sargodha, Punjab, Pakistan.
  • Junaid Matloob University of Chester, United Kingdom.
  • Abdul Ali Khan University of New Mexico, United States.
  • Shawaiz Sanaullah Zohra Institute of Health Sciences (GCUF), Rawalpindi, Punjab, Pakistan.
  • Mudassir Azeem Riphah International University, Islamabad, Pakistan.
  • Alishba Amin Zohra Institute of Health Sciences (GCUF), Rawalpindi, Punjab, Pakistan.
  • Hashmatullah Stanikzai Shaikh Khalifa Bin Zayed Al Nahyan Medical and Dental College, Lahore, Punjab, Pakistan.
  • Ali Husnain Zohra Institute of Health Sciences (GCUF), Rawalpindi, Punjab, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i8.1790

Keywords:

GDM, ESR, TLC, CRP, OGTT

Abstract

Gestational diabetes mellitus (GDM) is a prevalent metabolic complication in pregnancy, presenting considerable risks to maternal and fetal health. Recent studies indicate that inflammatory processes may contribute to the pathophysiology of GDM, leading to insulin resistance and modified immune responses. Inflammatory markers, including CRP, TLC, and ESR, are frequently utilized to evaluate systemic inflammation. This study aims to evaluate and compare inflammatory markers between GDM and non-diabetic pregnant females to elucidate their potential role in the progression and diagnosis of gestational diabetes mellitus (GDM). This research employed a cross-sectional study design and was conducted from May 2024 to September 2024. 120 participants were included with informed consent and divided into GDM (60) and control groups (60). The clinical features and demographics of patients were recorded using a structured interview questionnaire. Then, a blood sample was collected for laboratory analysis. The predominant clinical symptoms in individuals with gestational diabetes mellitus (GDM) were polydipsia, polyuria, and polyphagia. The unpaired t-test indicated a non-significant correlation of ESR levels between the two groups (p-value 0.06). Nonetheless, TLC and CRP levels exhibited a strong significant correlation between the GDM and control groups, with a p-value of <0.01. This research concluded that CRP and TLC are elevated in GDM patients in comparison to non-diabetic pregnant females.

Downloads

Download data is not yet available.

References

1- Elsayed NA, Aleppo G, Aroda VR, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 2023; 46:S19-S40. https://doi.org/10.2337/dc23-S002

2- Torres-Torres J, Monroy-Muñoz IE, Perez-Duran J, et al. Cellular and Molecular Pathophysiology of Gestational Diabetes. Int J Mol Sci. 2024; 25(21). https://doi.org/10.3390/ijms252111641

3- Scholarstica Chukwuemeka, Chivese, T., Gopinath, A., & Kenechukwu Obikeze. (2024). Adverse pregnancy outcomes in gestational diabetes mellitus: a systematic review and meta-analysis protocol. BMJ Open, 14(5), e058625–e058625. https://doi.org/10.1136/bmjopen-2021-058625

4- Stern C, Schwarz S, Moser G, et al. Placental endocrine activity: Adaptation and disruption of maternal glucose metabolism in pregnancy and the influence of fetal sex. Int J Mol Sci. 2021; 22(23). https://doi.org/10.3390/ijms222312722

5- Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011; 18(6):409-416. https://doi.org/10.1097/med.0b013e32834c800d

6- Mora-Ortiz M, Rivas-García L. Gestational Diabetes Mellitus: Unveiling Maternal Health Dynamics from Pregnancy through Postpartum Perspectives. Open Research Europe. 2024; 4:164. https://doi.org/10.12688/openreseurope.18026.2

7- Adnan M, Aasim M. Prevalence of gestational diabetes mellitus in Pakistan: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024; 24(1). https://doi.org/10.1186/s12884-024-06290-9

8- Dalfrà MG, Burlina S, Del Vescovo GG, Lapolla A. Genetics and Epigenetics: New Insight on Gestational Diabetes Mellitus. Front Endocrinol (Lausanne). 2020; 11. https://doi.org/10.3389/fendo.2020.602477

9- Nicolae Gică, & Iulia Huluță. (2023). GESTATIONAL DIABETES MELLITUS. IntechOpen EBooks. https://doi.org/10.5772/intechopen.1002793

10- Hafija Akter, Tamima Akter, Ummay Kulsum, Munira Parveen. Perinatal complications in women with gestational diabetes mellitus. Int J Res Med Sci. 2023; 11(5):1456-1459. https://doi.org/10.18203/2320-6012.ijrms20231023

11- Mehreen S, Usman M, Rauf K, Naz S, Sultan MARF, Randhawa MA. The Validity of 75gms OGTT for Detection of GDM Keeping 100gms OGTT As Gold Standard. Journal of Rawalpindi Medical College. 2023; 27(3). https://doi.org/10.37939/jrmc.v27i3.2336

12- Renz PB, Cavagnolli G, Weinert LS, Silveiro SP, Camargo JL. HbA1c test as a tool in the diagnosis of gestational diabetes mellitus. PLoS One. 2015; 10(8). https://doi.org/10.1371/journal.pone.0135989

13- Wolf, M., Sandler, L., Hsu, K., Vossen-Smirnakis, K., Ecker, J. L., & Thadhani, R. (2003). First-Trimester C-reactive protein and Subsequent Gestational Diabetes. Diabetes Care, 26(3), 819–824. https://doi.org/10.2337/diacare.26.3.819

14- Dasanayake, A. P., Chhun, N., Anne C.R. Tanner, Craig, R. G., Lee, M. J., Moore, A. F., & Norman, R. G. (2008). Periodontal Pathogens and Gestational Diabetes Mellitus. Journal of Dental Research, 87(4), 328–333. https://doi.org/10.1177/154405910808700421

15- Leipold, H., Worda, C., Gruber, C. J., Prikoszovich, T., Wagner, O., & Kautzky-Willer, A. (2005). Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester. European Journal of Clinical Investigation, 35(12), 752–757. https://doi.org/10.1111/j.1365-2362.2005.01574.x

16- Duo, Y., Song, S., Qiao, X., Zhang, Y., Xu, J., Zhang, J., Peng, Z., Chen, Y., Nie, X., Sun, Q., Yang, X., Wang, A., Sun, W., Fu, Y., Dong, Y., Lu, Z., Yuan, T., & Zhao, W. (2024). The Association of Hematological Parameters in Early and Middle Pregnancy with the Risk of Gestational Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity, 17, 633–646. https://doi.org/10.2147/DMSO.S445927

17- Habib, F. A. (2009). Evaluation of Periodontal Status Among Saudi Females with Gestational Diabetes and its Relation to Glucose and Lipid Homeostasis in Ohud Hospital, Al Madina Al-Munwarrah. International Journal of Health Sciences, 3(2), 143. https://pmc.ncbi.nlm.nih.gov/articles/PMC3068808/

18- He, Y., Ching Wan Ma, R., McIntyre, H. D., Sacks, D. A., Lowe, J., Catalano, P. M., & Tam, W. H. (2022). Comparing IADPSG and NICE Diagnostic Criteria for GDM in Predicting Adverse Pregnancy Outcomes. Diabetes Care, 45(9). https://doi.org/10.2337/dc22-0579

19- Nakshine, V. S., & Jogdand, S. D. (2023). A Comprehensive Review of Gestational Diabetes Mellitus: Impacts on Maternal Health, Fetal Development, Childhood Outcomes, and Long-Term Treatment Strategies. Cureus. https://doi.org/10.7759/cureus.47500

20- Monod, C., Kotzaeridi, G., Linder, T., Eppel, D., Rosicky, I., Filippi, V., Tura, A., Hösli, I., & Göbl, C. S. (2023). Prevalence of gestational diabetes mellitus in women with a family history of type 2 diabetes in first- and second-degree relatives. Acta Diabetologica, 60(3), 345–351. https://doi.org/10.1007/s00592-022-02011-w

21- Gao, J., Hua, Z., & Wu, A. (2022). Analysis on Family History of Diabetes, Weight Gain during Pregnancy and Pre-pregnancy Body Mass Index on 82 Pregnant Women with Gestational Diabetes Mellitus. Journal of Clinical and Nursing Research, 6, 101–104. https://doi.org/10.26689/jcnr.v6i1.2928

22- Al-Azemi, N., Diejomaoh, M. F., Angelaki, E., & Mohammed, A. T. (2014). Clinical presentation and management of diabetes mellitus in pregnancy. International Journal of Women’s Health, 6(1). https://doi.org/10.2147/IJWH.S52391

23- Torun, G. I. (2022). The Relationship Between Gestational Diabetes Mellitus and Adipocytokine Levels. SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital. https://doi.org/10.14744/semb.2022.62592

24- Naureen, T., Riaz, B., Mushtaq, A., Shabbir, E., Sohaib Nadeem, M., & Gohar, L. (2023). SERUM C REACTIVE PROTEIN AS AN INFLAMMATORY MARKER IN GESTATIONAL DIABETES MELLITUS. In Pak J Physiol (Vol. 19, Issue 3). http://www.pps.org.pk/PJP/19-3/Tallat.pdf3

25- Fazeleh Hezareh, Moghaddam-Banaem, L., & Shadab Shahali. (2021). The relationship between maternal serum Interleukin-6 and CRP levels at the first trimester of pregnancy and gestational diabetes occurrence. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.22038/ijogi.2021.18572

26- Ghasemi, V., Banaei, M., Kiani, Z., Ramezani Tehrani, F., & Saei Ghare Naz, M. (2025). Blood Cells Parameters in Second Trimester of Pregnancy and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. In Endocrinology, Diabetes and Metabolism (Vol. 8, Issue 1). John Wiley and Sons Inc. https://doi.org/10.1002/edm2.70024

27- Kağıtçı, M. (2024). Comparison of hemogram parameters in pregnant women with gestational diabetes mellitus and healthy pregnant women. Zeynep Kamil Medical Journal, 196–200. https://doi.org/10.14744/zkmj.2024.90775

28- Bahar, A., Ozra Akha, Mahdi Bordbar, Saeid Abediankenari, Rezaali mohammadpoor, Ehsani, Z., & Kashi, Z. (2020). Anti-Inflammatory Markers IL-10 and IL-35: Role in Developing Gestational Diabetes Mellitus. JOURNAL of CLINICAL and DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2020/44413.13883

Downloads

Published

2025-08-15

How to Cite

Rafique, A., Yasin, N., Hanif, A., Matloob, J., Khan, A. A., Sanaullah, S., Azeem, M., Amin, A., Stanikzai, H., & Husnain, A. (2025). Comparative Analysis of Inflammatory Markers (CRP, TLC, ESR) between Gestational Diabetes and Non-Diabetic Pregnant Females in Rawalpindi, Pakistan. Indus Journal of Bioscience Research, 3(8), 245-250. https://doi.org/10.70749/ijbr.v3i8.1790